|
PXK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66056057793185E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.78879133727605E-12 |
| Normal-vs-Stage2 |
2.62659893834893E-11 |
| Normal-vs-Stage3 |
2.66453525910038E-15 |
| Normal-vs-Stage4 |
1.62503344114384E-12 |
| Stage1-vs-Stage2 |
8.263600E-01 |
| Stage1-vs-Stage3 |
6.108500E-02 |
| Stage1-vs-Stage4 |
8.905000E-03 |
| Stage2-vs-Stage3 |
1.277800E-01 |
| Stage2-vs-Stage4 |
5.208300E-02 |
| Stage3-vs-Stage4 |
4.703800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.64668279012403E-12 |
| Normal-vs-AfricanAmerican |
1.44529999968057E-07 |
| Normal-vs-Asian |
9.15933995315754E-14 |
| Caucasian-vs-AfricanAmerican |
4.140200E-01 |
| Caucasian-vs-Asian |
6.469400E-01 |
| AfricanAmerican-vs-Asian |
3.414400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.10782519111308E-15 |
| Normal-vs-Female |
8.06021915877864E-14 |
| Male-vs-Female |
1.315210E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.79665179903077E-13 |
| Normal-vs-Age(41-60Yrs) |
1.65445435129641E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63147273468667E-12 |
| Normal-vs-Age(81-100Yrs) |
1.97290999999211E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.526400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.307600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.306000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.605400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.027600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.289600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.215900E-02 |
| Classical-VS-Follicular |
6.725600E-01 |
| Classical-VS-Other |
4.469600E-01 |
| Classical-VS-Normal |
1.88049575911009E-12 |
| Tall-VS-Follicular |
5.964500E-02 |
| Tall-VS-Other |
9.568000E-01 |
| Tall-VS-Normal |
6.55031584528842E-15 |
| Follicular-VS-Other |
4.959400E-01 |
| Follicular-VS-Normal |
1.93811633408814E-12 |
| Other-VS-Normal |
1.758810E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.80326930744013E-14 |
| Normal-vs-N1 |
1.62736490949555E-12 |
| N0-vs-N1 |
5.122100E-02 |
|
|
